Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/39616
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jones S.A. | en |
dc.contributor.author | Morand, Eric | en |
dc.date.accessioned | 2021-05-14T13:31:27Z | en |
dc.date.available | 2021-05-14T13:31:27Z | en |
dc.date.copyright | 2016 | en |
dc.date.created | 20160213 | en |
dc.date.issued | 2016-02-13 | en |
dc.identifier.citation | Nature Reviews Rheumatology. 12 (2) (pp 73-74), 2016. Date of Publication: 01 Feb 2016. | en |
dc.identifier.issn | 1759-4790 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/39616 | en |
dc.description.abstract | Since glucocorticoids were first used to treat patients with rheumatoid arthritis in 1949, they have become the most common therapy for inflammatory disorders; however, their use is associated with major metabolic adverse events. Here, we review three 2015 reports with clinical and fundamental implications for the use of glucocorticoid therapy in rheumatology.Copyright © 2016 Macmillan Publishers Limited. All rights reserved. | en |
dc.language | en | en |
dc.language | English | en |
dc.publisher | Nature Publishing Group (Houndmills, Basingstoke, Hampshire RG21 6XS, United Kingdom) | en |
dc.relation.ispartof | Nature Reviews Rheumatology | en |
dc.title | Glucocorticoids in 2015: New answers to old problems. | en |
dc.type | Review | en |
dc.identifier.affiliation | Rheumatology | - |
dc.type.studyortrial | Review article (e.g. literature review, narrative review) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/nrrheum.2015.176 | en |
dc.publisher.place | United Kingdom | en |
dc.identifier.pubmedid | 26698024 [http://www.ncbi.nlm.nih.gov/pubmed/?term=26698024] | en |
dc.identifier.source | 607383919 | en |
dc.identifier.institution | (Jones, Morand) Monash University Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, 246 Clayton Road, Melbourne, VIC 3168, Australia | en |
dc.description.address | E.F. Morand, Monash University Centre for Inflammatory Diseases, School of Clinical Sciences at Monash Health, 246 Clayton Road, Melbourne, VIC 3168, Australia. E-mail: eric.morand@monash.edu | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2016 Elsevier B.V., All rights reserved. | en |
dc.identifier.authoremail | Morand E.F.; eric.morand@monash.edu | en |
dc.description.grant | Organization: (LRI) *Lupus Research Institute* | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Review | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Rheumatology | - |
crisitem.author.dept | Centre for Inflammatory Diseases at Monash Health | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.